Guardian Pharmacy Services, Inc. achieved $1.45 billion in revenue and $49.2 million in net income for the fiscal year ending December 31, 2025, reflecting a profitable trajectory supported by scale and operational efficiency. Despite moderate liquidity metrics—current ratio of 1.38—the company maintains financial stability amid working capital demands typical in pharmacy services. Capital allocation decisions emphasize shareholder returns via buybacks, while regulatory and disclosure risks underline the need for cautious monitoring of earnings visibility going forward.